Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ACRP appoints chair of GCC

This article was originally published in SRA

Executive Summary

The US-based Association of Clinical Research Professionals has confirmed the appointment of Dr Satish Chandra as chairman of the association's Gulf Cooperative Council (GCC) Chapter. Dr Chandra is a specialist and head of clinical research at Tawam Hospital in the United Arab Emirates. Accredited with discovery of the first human immunophilin gene, and responsible for avid binding of the hormone progesterone, he has published extensively in international peer reviewed journals, as well as authoring two books in the area of molecular medicine. Dr Chandra said that the GCC was emerging as an "increasingly important location in terms if medical breakthroughs and clinical research" and that he hoped his new role would enable him to support further growth and developments.

You may also be interested in...

Hoops, hoopla, big ideas and diabetes

Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.

Scrip Asia 100 league tables 2013

How Dennis Gillings took a gamble and built a $3.7bn business

"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts